Ophthalmology 360
  • Conferences
  • Videos
  • Podcasts
  • Quizzes
  • About
    • About Us – Mission
    • Content Awards
    • Media Partners
    • Business Team
    • Brand Ambassadors
    • Photo Contest
    • Industry Council
    • Advisory Board

What are you looking for?

  • Anterior Segment
  • Cataract
  • Cornea and External Disease
  • Diabetic Macular Edema
  • Dry Eye
  • Early Onset Cataracts
  • Exclusives
  • General
  • Geographic Atrophy
  • Glaucoma
  • Industry News
  • Inherited Retinal Disease
  • IOLs
  • Neurotrophic Keratitis
  • Ocular Surface Disease
  • Oculoplastics
  • Optometry
  • Pediatrics
  • Practice Management
  • Presbyopia
  • Refractive Surgery/Vision Correction
  • Residents & Young Ophthalmologists
  • Retina
  • Retina Care 360
  • Retinopathy of Prematurity
  • Spotlight Series
  • The Interventional Glaucoma Project
  • The Ophthalmic Project
  • Trending Topics
2nd Annual Photo Contest - Enter Here!
Ophthalmology 360
  • Conferences
  • Videos
  • Podcasts
  • Quizzes
  • About
    • About Us – Mission
    • Content Awards
    • Media Partners
    • Business Team
    • Brand Ambassadors
    • Photo Contest
    • Industry Council
    • Advisory Board
Home > Practice Management > ImprimisRx Launch Telemedicine Solution with Doxy.me
  • Practice Management

ImprimisRx Launch Telemedicine Solution with Doxy.me

Ophthalmology 360
ImprimisRx Launch Telemedicine Solution with Doxy.me

Harrow Health, Inc and ImprimisRx announced an exclusive agreement with Doxy.me, a full-service telemedicine solution, that will allow ImprimisRx ophthalmology, optometry, and wellness practices to use the clinic level telemedicine solution at no charge. The software allows providers to use video, audio, and text to communicate remotely with patients.

“Earlier this month the Centers for Medicare and Medicaid Services (CMS) announced it would temporarily pay clinicians to provide telemedicine services for beneficiaries across the country and loosen other restrictions due to the disruptions caused by COVID-19,” said John Saharek, President of ImprimisRx, in a press release. “Because we believe it is critical that ImprimisRx customers and all ophthalmologists, optometrists, and wellness providers maintain continuity of care, regardless of external circumstances, we are pleased to now provide Doxy.me along with our mail-order pharmacy services – that can rapidly ship prescription medicines into all 50 states. I believe our valued prescriber customers will quickly adapt to the amazing benefits of the Doxy.me platform and begin utilizing it to meet their patients’ needs.”

Read the company’s full press release here.

 

Source: ImprimisRx

Share

Related Content

  • Podcasts

Should you consider a pathway to clinical vision research?

37 Mins Listen
  • Practice Management

Global comparison shows significant differences in waste generated during eye surgery

  • Practice Management

ZEISS turns 100: the evolution of vision care, ophthalmology, and optical innovation

  • IOLs

Sustainability in ophthalmology: actionable tips

  • Practice Management

New review highlights urgent need to tackle adherence gaps in eye care throughout the patient life cycle

  • Trending Topics

Ophthalmic drugs account for a significant share of US drug shortages

Share

Editor's Picks

  • Neurotrophic Keratitis

Topical insulin shows real-world benefit in neurotrophic keratopathy

  • Retina

GLP-1 RAs have protective effects against AMD

  • Retina

Four-month injection intervals appear safe for long-term stable nAMD

Advisory Board

Saad Ahmad, MD

Ahmad A. Aref, MD, MBA

Roomasa Channa, MD

David Chow, MD, FRCS(C)

Sally L. Baxter, MD, MSc

Neel R. Desai, MD

Nadia Haqqie, MD

Simon Fung, MD, FRCOphth

Sumit Garg, MD

Ross Lakhanpal, MD, FACS

Sanjai Jalaj, MD

Anton Kolomeyer, MD, PhD

Shan Lin, MD

Steven R. Sarkisian, Jr., MD

See All
Ophthalmology 360

Ophthalmology 360® is a dynamic digital platform dedicated to advancing the field of eye care.

Get to Know Us

  • Home
  • About Us
  • Media Partners
  • Advertising Policy
  • Our Advisory Board

Sign up for our Newsletter

Sign up for our Newsletter to get our newest articles instantly!

  • Privacy Policy
  • Advertising Policy
  • Medical Disclaimer
IHM Logo

2026 Ophthalmology 360 is a trademark of International Healthcare Media, LLC. All rights reserved

  • MedJournal360 Icon
  • RareDisease360 Icon
  • MyHero360 Icon
  • Optometry360 Icon
  • Ophtalmology360 Icon